Search - tctmd.com

Displaying 381 - 400 of 627

Sort: Relevancy | Date

Presentation TCT 2017

Coronary Revascularization for CHF: Implications From STICH for Complete Revascularization

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Eric Jose Velazquez

October 31, 2017

Presentation TCT 2017

US and EU Guidelines for Drug and Device Management of Heart Failure: Overview, Similarities, and Differences

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, William T. Abraham

October 31, 2017

Presentation TCT 2017

First of the Class: Tissue Engineering

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Andreu M Climent

October 31, 2017

Presentation TCT 2017

Diagnosis and Treatment Options for RV Shock

Presenter: Vladimir Dzavik, Navin K. Kapur, James A. Goldstein

October 31, 2017

Presentation TCT 2017

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

Presenter: Vladimir Dzavik, Navin K. Kapur, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

New Strategies for a Chronic Scenario: Combinative Approaches

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Amit N. Patel

October 31, 2017

Presentation TCT 2017

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

Presenter: Vladimir Dzavik, Navin K. Kapur, Christian M. Spaulding

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

New Targets: Heart Failure With Preserved Ejection Fraction

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Eugenio Cingolani

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Presenter: Vladimir Dzavik, Navin K. Kapur, Robb Kociol

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of Impella

Presenter: Vladimir Dzavik, Navin K. Kapur, Mark B. Anderson

October 31, 2017

Presentation TCT 2017

In Which Direction is Cell Based Heart Failure Therapy Headed?

Presenter: Francisco Fdez-Aviles, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Presenter: Vladimir Dzavik, Navin K. Kapur, David A Baran

October 31, 2017

Presentation TCT 2017

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Presenter: Vladimir Dzavik, Navin K. Kapur, Nicolas M. Van Mieghem

October 31, 2017

Presentation TCT 2017

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Presenter: Vladimir Dzavik, Navin K. Kapur, Holger Thiele

October 31, 2017

Presentation TCT 2017

Colombia Presents to Ukraine: Pulmonary Valvuloplasty and Concomitant LAD PCI

Presenter: Mohammad Al-Mutairi, Ahmed Magdy, Jorge Villegas

October 31, 2017

Presentation TCT 2017

Editorial Perspective: End-stage HF Treatment: Time for An Interventional Approach?

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Daniel Burkhoff

October 31, 2017

Presentation TCT 2017

Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Emerson C. Perin

October 31, 2017

Presentation TCT 2017

Editorial Perspective: The Evolving Role of LVAD in Interventional HF

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, Ileana L. Pina

October 31, 2017

Presentation TCT 2017

Soft Robotic Cardiac Assist Device for Heart Failure Patients (CorInnova)

Presenter: Louis A. Cannon, Peter J. Fitzgerald, Juan F. Granada, William C Altman

October 31, 2017

Advertisement

Coronary Revascularization for CHF: Implications From STICH for Complete Revascularization

US and EU Guidelines for Drug and Device Management of Heart Failure: Overview, Similarities, and Differences

First of the Class: Tissue Engineering

Diagnosis and Treatment Options for RV Shock

Cardiogenic Shock in the Elderly: Rational Treatment Suggestions

New Strategies for a Chronic Scenario: Combinative Approaches

Cardiac Arrest With Cardiogenic Shock: Specific Management Considerations

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

New Targets: Heart Failure With Preserved Ejection Fraction

Acute Cardiogenic Shock: The Case for First-line Use of ECMO

Acute Cardiogenic Shock: The Case for First-line Use of Impella

In Which Direction is Cell Based Heart Failure Therapy Headed?

Acute Cardiogenic Shock: The Case for First-line Use of IABP

Synthesis of Randomized Trial and Registry Data for Devices in Cardiogenic Shock: What Is the Evidence for Efficacy?

Acute Cardiogenic Shock: Pathophysiology, Hemodynamics, and Treatment Goals

Colombia Presents to Ukraine: Pulmonary Valvuloplasty and Concomitant LAD PCI

Editorial Perspective: End-stage HF Treatment: Time for An Interventional Approach?

Editorial Perspective: Device-based Neuromodulation and Interventional HF Therapy

Editorial Perspective: The Evolving Role of LVAD in Interventional HF

Soft Robotic Cardiac Assist Device for Heart Failure Patients (CorInnova)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content